Heterogeneity of alcohol use disorder: understanding mechanisms to advance personalized treatment.
paper
Cited
Public
Unavailable
- Authors
- Litten, Raye Z; Ryan, Megan L; Falk, Daniel E; Reilly, Matthew; Fertig, Joanne B; Koob, George F
- Year
- 2015
- Journal
- Alcoholism, clinical and experimental research
- PMID
- 25833016
- DOI
- 10.1111/acer.12669
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Causes for Treatment Discontinuation in a Greek Public Residential Inpatient Therapeutic Program for Alcohol Use Disorder. | Segredou E et al. | β | 2026 | β |
| Classification of Patients According to the Lesch Alcoholism Typology in a Public Inpatient Residential Therapeutic Program for Alcohol Use Disorder. | Papaefstathiou G et al. | β | 2026 | β |
| Diagnostic validity of Addictions Neuroclinical Assessment indices for alcohol use disorder: Findings from an observational case-control study. | Garber ML et al. | β | 2026 | β |
| Exploring neural markers of incentive salience and real-world drinking among individuals with alcohol use disorder. | Kang D et al. | β | 2026 | β |
| Glia in the Spotlight: The Cellular Basis of Alcohol Use Disorder. | Codeluppi-Arrowsmith SA et al. | β | 2026 | β |
| Gut microbiome-derived tryptophan metabolites predict relapse in alcohol use disorder. | Forton C et al. | β | 2026 | β |
| Nalmefene and naltrexone reduce alcohol intake via selective efficacy in subpopulations distinguished by behavioral and blood-based biomarkers. | Farahbakhsh ZZ et al. | β | 2026 | β |
| Pharmacological interventions for alcohol use disorder: novel insights from recent clinical trials. | McManus KR et al. | β | 2026 | β |
| Prenatal antioxidant treatment suppresses maternal immune activation induced increases in alcohol self-administration in a sex-specific manner. | Nicholson SE et al. | β | 2026 | β |
| Sex and individual differences in ketamine's effects on alcohol drinking in rats. | Jennings SD et al. | β | 2026 | β |
| Sexual Identity Uncertainty and Risk of Alcohol Use Disorder: The Roles of Tension Reduction Beliefs and Coping Motives. | Wantje M et al. | β | 2026 | β |
| The Pharmaceutically Enhanced Reinforcement for Reduced Alcohol and Smoking (PERRAS) Study: Protocol for a randomized clinical trial. | Palombo P et al. | β | 2026 | β |
| Adolescent substance use trajectories are associated with nucleus accumbens functional connectivity. | Purcell JB et al. | β | 2025 | β |
| Alcohol reduction strategies among persons with hiv: past attempts, self-reported effectiveness, and future strategies of interest. | Siuluta N et al. | β | 2025 | β |
| Drinking motives and alcohol sensitivity mediate multidimensional genetic influences on alcohol use behaviors. | Savage JE et al. | β | 2025 | β |
| Effects of a drinking motives and readiness to change tailored digital alcohol intervention among online help-seekers: protocol for a randomised controlled trial. | Crawford J et al. | β | 2025 | β |
| Genetic risk for alcohol use disorder in relation to individual symptom criteria: Do polygenic indices provide unique information for understanding severity and heterogeneity? | Sarles YM et al. | β | 2025 | β |
| Heterogeneity across idiographic network associations among emotion dysregulation, alcohol use, posttraumatic stress symptoms, and intimate partner violence. | Brick LA et al. | β | 2025 | β |
| Hierarchical taxonomy of psychopathology and personalized mental health treatment selection. | Argyriou E et al. | β | 2025 | β |
| How do participant preferences, expectancies, and perceptions of ecological momentary assessment impact adherence? A mixed-methods analysis. | Piccirillo ML et al. | β | 2025 | β |
| Identification of potential therapeutic targets for problematic alcohol use using multi-omics data. | Lee DJ et al. | β | 2025 | β |
| Modeling social cognition in alcohol use disorder: lessons from schizophrenia. | Perini I et al. | β | 2025 | β |
| Motives for Cannabis Use and Readiness to Change Among Users of the "Stop-Cannabis" Mobile App: Cluster Analysis. | Wegener M et al. | β | 2025 | β |
| Precision medicine in substance use disorders: Integrating behavioral, environmental, and biological insights. | Guerrin CGJ et al. | β | 2025 | β |
| Role of Drinking Attitudes and Trait Impulsivity in Prenatal Alcohol Craving and Consumption in Mothers of Reproductive Age. | Hayashi Y et al. | β | 2025 | β |
| Sex-based differences across the stages of the addiction cycle among adults with severe alcohol use disorder. | Parlier-Ahmad AB et al. | β | 2025 | β |
| Sphingosine-1-phosphate (S1P) signaling as a novel therapeutic target for alcohol abuse | Lorrai I et al. | β | 2025 | β |
| Subtypes of cocaine use disorder and their neurobehavioral profiles. | Brucar LR et al. | β | 2025 | β |
| The Effects of Alcohol in Groups of Heavy Drinking Young Adults: A Multi-Modal Investigation of Alcohol Responses in a Laboratory Social Setting. | Creswell KG et al. | β | 2025 | β |
| A machine learning personalized treatment rule to optimize assignment to psychotherapies for grief among veterans. | Argyriou E et al. | β | 2024 | β |
| Cognitive Alterations Associated with Remission and Alcohol Dependence Severity in Ethnically Diverse Patients of Siberia. | Peshkovskaya A | β | 2024 | β |
| Comparing the psychometric properties of reward and relief drinking measures. | Votaw VR et al. | β | 2024 | β |
| Designing and testing treatments for alcohol use disorder. | Witkiewitz K et al. | β | 2024 | β |
| Distinct Chrna5 mutations link excessive alcohol use to types I/II vulnerability profiles and IPN GABAergic neurons. | Tochon L et al. | β | 2024 | β |
| Effects of alcohol problem discrepancy on relationship adjustment: The moderating role of conflict negotiation among couples with alcohol use disorder and intimate partner violence. | Flanagan JC et al. | β | 2024 | β |
| Effects of a novel GABA-B positive allosteric modulator, ASP8062, on alcohol cue-elicited craving and naturalistic alcohol consumption in a multisite randomized, double-blind, placebo-controlled trial. | Schacht JP et al. | β | 2024 | β |
| Effects of prazosin treatment on liver enzymes are moderated by alcohol withdrawal symptoms in individuals with alcohol use disorder. | Martins BS et al. | β | 2024 | β |
| Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder. | KΓΆhne S et al. | β | 2024 | β |
| Evidence-Based Assessment of Substance Use Disorder. | Boness CL et al. | β | 2024 | β |
| Examining the validity of the addictions neuroclinical assessment domains in a crowdsourced sample of adults with current alcohol use. | Votaw VR et al. | β | 2024 | β |
| Factors underlying the neurofunctional domains of the Addictions Neuroclinical Assessment assessed by a standardized neurocognitive battery. | Gunawan T et al. | β | 2024 | β |
| Functional Domains of Substance Use and their Implications to Trauma: A Systematic Review of Neuroimaging Studies. | Hinojosa CA et al. | β | 2024 | β |
| Identifying neurofunctional domains across substance use disorders. | Hartwell EE et al. | β | 2024 | β |
| Initial Psychometric Testing of the Harm Reduction Self-Efficacy Scale (HRSES). | Schwebel FJ et al. | β | 2024 | β |
| Insights from genetically stratified analyses comparing subtypes of alcohol misuse. | Savage JE et al. | β | 2024 | β |
| Longitudinal measurement invariance of constructs derived from the addiction cycle. | Boness CL et al. | β | 2024 | β |
| Longitudinal stability of reward and relief drinking phenotypes in community and treatment-seeking individuals who engage in heavy drinking. | Hebden HM et al. | β | 2024 | β |
| Machine Learning of Functional Connectivity to Biotype Alcohol and Nicotine Use Disorders. | Zhu T et al. | β | 2024 | β |
| Neural correlates of the addictions neuroclinical assessment (ANA) incentive salience factor among individuals with alcohol use disorder. | Nieto SJ et al. | β | 2024 | β |
| Optimizing Allocation to Telehealth and In-Person Prolonged Exposure for Women Veterans with Military Sexual Trauma: A Precision Medicine Approach. | Argyriou E et al. | β | 2024 | β |
| Reward, relief, and habit drinking profiles in treatment seeking individuals with an AUD. | Grodin EN et al. | β | 2024 | β |
| Should we promote alcohol problems as a continuum? Implications for policy and practice. | Morris J et al. | β | 2024 | β |
| Social Media as Pharmacovigilance: The Potential for Patient Reports to Inform Clinical Research on Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists for Substance Use Disorders. | Bremmer MP et al. | β | 2024 | β |
| Spontaneous flexibility, attentional set shifting and cognitive control in men with alcohol dependence. | Zawadzka E et al. | β | 2024 | β |
| State of the Science: Treatment of comorbid posttraumatic stress disorder and substance use disorders. | Back SE et al. | β | 2024 | β |
| Stress and substance use disorders: risk, relapse, and treatment outcomes. | Sinha R | β | 2024 | β |
| The Limbic System in Co-Occurring Substance Use and Anxiety Disorders: A Narrative Review Using the RDoC Framework. | Lin ER et al. | β | 2024 | β |
| The role of resilience in the relationship between stress and alcohol. | Schwandt ML et al. | β | 2024 | β |
| Toward AI-driven neuroepigenetic imaging biomarker for alcohol use disorder: A proof-of-concept study. | Dagnew TM et al. | β | 2024 | β |
| Validation of predicted individual treatment effects in out of sample respondents. | Kuhlemeier A et al. | β | 2024 | β |
| Variants of the P3 event-related potential operate as indicators of distinct mechanisms contributing to problematic alcohol use. | Joyner KJ et al. | β | 2024 | β |
| Adolescent alcohol disrupts development of noradrenergic neurons in the nucleus of the tractus solitarius and enhances stress behaviors in adulthood in mice in a sex specific manner. | Aguilar LA et al. | β | 2023 | β |
| Alcohol use disorder criteria exhibit different comorbidity patterns. | Watts AL et al. | β | 2023 | β |
| An intensive longitudinal examination of topiramate treatment for alcohol use disorder: a secondary analysis of data from a randomized controlled trial. | Votaw VR et al. | β | 2023 | β |
| Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study. | Grodin EN et al. | β | 2023 | β |
| Constructs derived from the addiction cycle predict alcohol use disorder treatment outcomes and recovery 3 years following treatment. | Witkiewitz K et al. | β | 2023 | β |
| Development and clinical feasibility study of a brief version of an addiction-focused phenotyping battery in females receiving buprenorphine for opioid use disorder. | Parlier-Ahmad AB et al. | β | 2023 | β |
| Diagnostic Criteria for Identifying Individuals at High Risk of Progression From Mild or Moderate to Severe Alcohol Use Disorder. | Miller AP et al. | β | 2023 | β |
| Effects of dulaglutide on alcohol consumption during smoking cessation. | Probst L et al. | β | 2023 | β |
| Examining the validity of the drinking motives questionnaire for identifying reward and relief drinking subgroups in college students. | Hebden HM et al. | β | 2023 | β |
| Incremental Predictive Validity of the Dualistic Model of Passion for Cannabis Use Among College Undergraduate Students With and Without a Cannabis Use Disorder. | Davis AK et al. | β | 2023 | β |
| Initial Validation of a Behavioral Phenotyping Model for Substance Use Disorder. | Keyser-Marcus L et al. | β | 2023 | β |
| Investigating genetically stratified subgroups to better understand the etiology of alcohol misuse. | Thijssen AB et al. | β | 2023 | β |
| Ketamine Treatment for Alcohol Use Disorder: A Systematic Review. | Kelson M et al. | β | 2023 | β |
| (Mis)understanding alcohol use disorder: Making the case for a public health first approach. | Morris J et al. | β | 2023 | β |
| New approaches to deep phenotyping in addictions. | Watts AL et al. | β | 2023 | β |
| Pathways of personality and learning risk for addictive behaviors: A systematic review of mediational research on the acquired preparedness model. | Halvorson MA et al. | β | 2023 | β |
| Patterns of drinking behavior around a treatment episode for alcohol use disorder: Predictions from pre-treatment measures. | Witkiewitz K et al. | β | 2023 | β |
| Phenobarbital versus benzodiazepines in alcohol withdrawal syndrome. | Malone D et al. | β | 2023 | β |
| Precision medicine in alcohol use disorder: Mapping etiologic and maintenance mechanisms to mechanisms of behavior change to improve patient outcomes. | Boness CL et al. | β | 2023 | β |
| Structured tracking of alcohol reinforcement (STAR) for basic and translational alcohol research. | Brown AR et al. | β | 2023 | β |
| Subtypes in addiction and their neurobehavioral profiles across three functional domains. | Drossel G et al. | β | 2023 | β |
| The Impact of Cue-Elicited Multisensory Imagery on Alcohol Craving: A Randomised Controlled Trial. | Kiyak C et al. | β | 2023 | β |
| Transferring the approach avoidance task into virtual reality: a study in patients with alcohol use disorder versus healthy controls. | Ascone L et al. | β | 2023 | β |
| Translational models of addiction phenotypes to advance addiction pharmacotherapy. | Ray LA et al. | β | 2023 | β |
| Triple Diagnosis of Attention-Deficit/Hyperactivity Disorder with Coexisting Bipolar and Alcohol Use Disorders: Clinical Aspects and Pharmacological Treatments. | Weiss F et al. | β | 2023 | β |
| Alcohol craving and withdrawal at treatment entry prospectively predict alcohol use outcomes during outpatient treatment. | Martins JS et al. | β | 2022 | β |
| Alcohol solution strength preference predicts compulsive-like drinking behavior in rats. | Foo JC et al. | β | 2022 | β |
| Alcohol withdrawal symptoms predict corticostriatal dysfunction that is reversed by prazosin treatment in alcohol use disorder. | Sinha R et al. | β | 2022 | β |
| A Novel Graphical Method for Data Presentation in Alcohol Systematic Reviews: The Interactive Harvest Plot. | Foulds J et al. | β | 2022 | β |
| Applying the Addictions Neuroclinical Assessment to derive neurofunctional domains in individuals who use methamphetamine. | Nieto SJ et al. | β | 2022 | β |
| A review of functional brain differences predicting relapse in substance use disorder: Actionable targets for new methods of noninvasive brain stimulation. | Gibson BC et al. | β | 2022 | β |
| Are we compulsively chasing rainbows? | George O et al. | β | 2022 | β |
| Assessing negative affect in mice during abstinence from alcohol drinking: Limitations and future challenges. | Bloch S et al. | β | 2022 | β |
| Associations between specific sleep and circadian characteristics and alcohol use disorder criteria and problems. | Boness CL et al. | β | 2022 | β |
| Behavioral response bias and event-related brain potentials implicate elevated incentive salience attribution to alcohol cues in emerging adults with lower sensitivity to alcohol. | CofresΓ RU et al. | β | 2022 | β |
| Closing the brain-heart loop: Towards more holistic models of addiction and addiction recovery. | Eddie D et al. | β | 2022 | β |
| Examining a brief measure and observed cutoff scores to identify reward and relief drinking profiles: Psychometric properties and pharmacotherapy response. | Votaw VR et al. | β | 2022 | β |
| Exploration of the Impact of Combining Risk Phenotypes on the Likelihood of Alcohol Problems in Young Adults. | Kampov-Polevoy A et al. | β | 2022 | β |
| Exposure to Olfactory Alcohol Cues During Non-rapid Eye Movement Sleep Did Not Decrease Craving in Patients With Alcohol Dependence. | Zhu R et al. | β | 2022 | β |
| Functional connectivity in the central executive network predicts changes in binge drinking behavior during emerging adulthood: an observational prospective study. | Lesnewich LM et al. | β | 2022 | β |
| Genetically influenced externalizing and internalizing risk pathways as novel prevention targets. | Dick DM et al. | β | 2022 | β |
| Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts. | Mallard TT et al. | β | 2022 | β |
| Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder. | Burnette EM et al. | β | 2022 | β |
| Predictors of abstinence, no heavy drinking days, and a 2-level reduction in World Health Organization drinking levels during treatment for alcohol use disorder in the COMBINE study. | Wallach JD et al. | β | 2022 | β |
| Prevalence and Treatment for Alcohol Use Disorders Based on Kentucky Medicaid 2012-2019 Datasets. | Hu H et al. | β | 2022 | β |
| RNA biomarkers for alcohol use disorder. | Ferguson LB et al. | β | 2022 | β |
| The Utility of Research Domain Criteria in Diagnosis and Management of Dual Disorders: A Mini-Review. | Hakak-Zargar B et al. | β | 2022 | β |
| Using Imagination to Integrate Contextual Effects in a Cue-Reactivity Paradigm in Patients with Alcohol Use Disorder: A Functional Magnetic Resonance Imaging Pilot Study. | Fey W et al. | β | 2022 | β |
| A Longitudinal Mediation Model of Negative Emotionality, Coping Motives and Drinking Intensity Among Individuals Receiving Community Treatment for Alcohol Use Disorder. | Votaw VR et al. | β | 2021 | β |
| An integrated multimodal model of alcohol use disorder generated by data-driven causal discovery analysis. | Rawls E et al. | β | 2021 | β |
| Applying methods for personalized medicine to the treatment of alcohol use disorder. | Kuhlemeier A et al. | β | 2021 | β |
| A unifying translational framework to advance treatment research for comorbid PTSD and substance use disorders. | Hien DA et al. | β | 2021 | β |
| Does crude measurement contribute to observed unidimensionality of psychological constructs? A demonstration with DSM-5 alcohol use disorder. | Watts AL et al. | β | 2021 | β |
| Hegemony, homogeneity, and DSM-5 SUD. | Strain EC | β | 2021 | β |
| Heterogeneity in DSM-5 Symptom Criteria: Phenotypes of Alcohol Use Disorder in a Sample Seeking Alcohol Treatment. | Zhao J et al. | β | 2021 | β |
| Mapping data-driven individualized neurobehavioral phenotypes in heavy alcohol drinkers. | DeMartini KS et al. | β | 2021 | β |
| Modeling Temporal Biomarkers With Semiparametric Nonlinear Dynamical Systems. | Sun BM et al. | β | 2021 | β |
| Moderation of Prazosin's Efficacy by Alcohol Withdrawal Symptoms. | Sinha R et al. | β | 2021 | β |
| Moderators of Substance Use Disorder Treatment for Adolescents. | Bachrach RL et al. | β | 2021 | β |
| Neural correlates of alcohol use disorder severity among nontreatment-seeking heavy drinkers: An examination of the incentive salience and negative emotionality domains of the alcohol and addiction research domain criteria. | Al-Khalil K et al. | β | 2021 | β |
| Neurobiological correlates of cue-reactivity in alcohol-use disorders: A voxel-wise meta-analysis of fMRI studies. | Zeng J et al. | β | 2021 | β |
| Occupancy of the kappa opioid receptor by naltrexone predicts reduction in drinking and craving. | de Laat B et al. | β | 2021 | β |
| Persistent attention-deficit/hyperactivity disorder predicts socially oriented, but not physical/physiologically oriented, alcohol problems in early adulthood. | Wang FL et al. | β | 2021 | β |
| Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review. | Mistarz N et al. | β | 2021 | β |
| Reward drinking and naltrexone treatment response among young adult heavy drinkers. | Roos CR et al. | β | 2021 | β |
| The Association Between Impulsivity and Relapse in Patients With Alcohol Use Disorder: A Literature Review. | Sliedrecht W et al. | β | 2021 | β |
| The Etiologic, Theory-Based, Ontogenetic Hierarchical Framework of Alcohol Use Disorder: A Translational Systematic Review of Reviews. | Boness CL et al. | β | 2021 | β |
| The future of translational research on alcohol use disorder. | Ray LA et al. | β | 2021 | β |
| The profound heterogeneity of substance use disorders: Implications for treatment development. | Carroll KM | β | 2021 | β |
| The Shape of Change: Determining When Mechanisms of Behavior Change Are Active in Cognitive Behavioral Treatment for Alcohol Use Disorder Using Time-Varying Effect Modeling (TVEM). | Linn BK et al. | β | 2021 | β |
| Use of Nalmefene in Routine Practice: Results from a French Prospective Cohort Study and a National Database Analysis. | Aubin HJ et al. | β | 2021 | β |
| Validity and measurement invariance of the Addictions Neuroclinical Assessment incentive salience domain among treatment-seekers with alcohol use disorder. | Stein ER et al. | β | 2021 | β |
| What do clinicians want? Understanding frontline addiction treatment clinicians' preferences and priorities to improve the design of measurement-based care technology. | Tauscher JS et al. | β | 2021 | β |
| Acetylcholine Muscarinic M<sub>4</sub> Receptors as a Therapeutic Target for Alcohol Use Disorder: Converging Evidence From Humans and Rodents. | Walker LC et al. | β | 2020 | β |
| A Distinct Neurophenotype of Fearful Face Processing in Alcohol Use Disorder With and Without Comorbid Anxiety. | MacIlvane N et al. | β | 2020 | β |
| A Systematic Review of the Self-Medication Hypothesis in the Context of Posttraumatic Stress Disorder and Comorbid Problematic Alcohol Use. | Hawn SE et al. | β | 2020 | β |
| Clinical Trials for Opioid Use Disorder. | Blessing E et al. | β | 2020 | β |
| Cortisol as a Biomarker of Alcohol Use in Combat Veterans: A Literature Review and Framework for Future Research. | Szabo YZ et al. | β | 2020 | β |
| Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline. | Miranda R et al. | β | 2020 | β |
| Five Priority Areas for Improving Medications Development for Alcohol Use Disorder and Promoting Their Routine Use in Clinical Practice. | Litten RZ et al. | β | 2020 | β |
| Gabapentin Enacarbil Extended-Release Versus Placebo: A Likely Responder Reanalysis of a Randomized Clinical Trial. | Laska EM et al. | β | 2020 | β |
| Hypothesizing High Negative Emotionality as a Function of Genetic Addiction Risk Severity (GARS) Testing in Alcohol Use Disorder (AUD). | Blum K et al. | β | 2020 | β |
| Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies. | Leggio L et al. | β | 2020 | β |
| Mifepristone Decreases Chronic Voluntary Ethanol Consumption in Rhesus Macaques. | Jimenez VA et al. | β | 2020 | β |
| Neuropsychophysiological Measures of Alcohol Dependence: Can We Use EEG in the Clinical Assessment? | Jurado-Barba R et al. | β | 2020 | β |
| OPRM1 Moderates Daily Associations of Naltrexone Adherence With Alcohol Consumption: Preliminary Evidence From a Mobile Health Trial. | Hendershot CS et al. | β | 2020 | β |
| Personalized Models of Psychopathology. | Wright AGC et al. | β | 2020 | β |
| PhenX: Host: Social/Cognitive measures for tobacco regulatory research. | Piper ME et al. | β | 2020 | β |
| Systematic review and meta-analysis of the moderating effect of rs1799971 in OPRM1, the mu-opioid receptor gene, on response to naltrexone treatment of alcohol use disorder. | Hartwell EE et al. | β | 2020 | β |
| The Addictions Neuroclinical Assessment Negative Emotionality Domain Among Treatment-Seekers with Alcohol Use Disorder: Construct Validity and Measurement Invariance. | Votaw VR et al. | β | 2020 | β |
| The ventral pallidum and relapse in alcohol seeking. | Prasad AA et al. | β | 2020 | β |
| Tumour Necrosis Factor in Neuroplasticity, Neurogenesis and Alcohol Use Disorder. | Alvarez Cooper I et al. | β | 2020 | β |
| A day-by-day prospective analysis of stress, craving and risk of next day alcohol intake during alcohol use disorder treatment. | Wemm SE et al. | β | 2019 | β |
| Advances in the science and treatment of alcohol use disorder. | Witkiewitz K et al. | β | 2019 | β |
| Advancing Precision Medicine for Alcohol Use Disorder: Replication and Extension of Reward Drinking as a Predictor of Naltrexone Response. | Witkiewitz K et al. | β | 2019 | β |
| Animal models in addiction research: A dimensional approach. | Lamontagne SJ et al. | β | 2019 | β |
| Are Some Alcohol Use Disorder Criteria More (or Less) Externalizing than Others? Distinguishing Alcohol Use Symptomatology from General Externalizing Psychopathology. | McDowell YE et al. | β | 2019 | β |
| A structural MRI study of differential neuromorphometric characteristics of binge and heavy drinking. | Maksimovskiy AL et al. | β | 2019 | β |
| Brain Imaging-Guided Analysis Reveals DNA Methylation Profiles Correlated with Insular Surface Area and Alcohol Use Disorder. | Zhao Y et al. | β | 2019 | β |
| Compulsivity in Alcohol Use Disorder and Obsessive Compulsive Disorder: Implications for Neuromodulation. | Burchi E et al. | β | 2019 | β |
| Deriving alternative criteria sets for alcohol use disorders using statistical optimization: Results from the National Survey on Drug Use and Health. | Boness CL et al. | β | 2019 | β |
| Different Characteristics and Heritabilities of Alcohol Use Disorder Classes: A Population-Based Swedish Study. | Long EC et al. | β | 2019 | β |
| Dynamic Features of Problematic Drinking: Alcohol Use Disorder Latent Classes Across Ages 18-64. | Linden-Carmichael AN et al. | β | 2019 | β |
| Evidence for incentive salience sensitization as a pathway to alcohol use disorder. | CofresΓ RU et al. | β | 2019 | β |
| Focusing personality assessment on the person: Modeling general, shared, and person specific processes in personality and psychopathology. | Wright AGC et al. | β | 2019 | β |
| Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and Safety. | Falk DE et al. | β | 2019 | β |
| Identifying Triggers of Alcohol Craving to Develop Effective Virtual Environments for Cue Exposure Therapy. | GhiΕ£Δ A et al. | β | 2019 | β |
| Interactive Effects of Naturalistic Drinking Context and Alcohol Sensitivity on Neural Alcohol Cue-Reactivity Responses. | Martins JS et al. | β | 2019 | β |
| Its complicated: The relationship between alcohol and microglia in the search for novel pharmacotherapeutic targets for alcohol use disorders. | Melbourne JK et al. | β | 2019 | β |
| Methodological Advances in Leveraging Neuroimaging Datasets in Adolescent Substance Use Research. | Beltz AM et al. | β | 2019 | β |
| Mindfulness-Based Relapse Prevention and Transcranial Direct Current Stimulation to Reduce Heavy Drinking: A Double-Blind Sham-Controlled Randomized Trial. | Witkiewitz K et al. | β | 2019 | β |
| Mobile alcohol biosensors and pharmacotherapy development research. | Roberts W et al. | β | 2019 | β |
| Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice. | Huynh N et al. | β | 2019 | β |
| Neurofunctional Domains Derived From Deep Behavioral Phenotyping in Alcohol Use Disorder. | Kwako LE et al. | β | 2019 | β |
| State-of-the-art behavioral and pharmacological treatments for alcohol use disorder. | Ray LA et al. | β | 2019 | β |
| The association between <i>HTR1B</i> gene rs13212041 polymorphism and onset of alcohol abuse. | Svob Strac D et al. | β | 2019 | β |
| What Is Addiction? How Can Animal and Human Research Be Used to Advance Research, Diagnosis, and Treatment of Alcohol and Other Substance Use Disorders? | Bickel WK et al. | β | 2019 | β |
| Withdrawal effects following repeated ethanol exposure are prevented by N-acetylcysteine in zebrafish. | Mocelin R et al. | β | 2019 | β |
| Addiction Biomarkers: Dimensional Approaches to Understanding Addiction. | Kwako LE et al. | β | 2018 | β |
| Advancing Pharmacotherapy Development from Preclinical Animal Studies. | Egli M | β | 2018 | β |
| Application of Research Domain Criteria to childhood and adolescent impulsive and addictive disorders: Implications for treatment. | Yip SW et al. | β | 2018 | β |
| Applications of virtual reality in individuals with alcohol misuse: A systematic review. | GhiΕ£Δ A et al. | β | 2018 | β |
| A Randomized Trial of Personalized Cognitive-Behavior Therapy for Alcohol Use Disorder in a Public Health Clinic. | Coates JM et al. | β | 2018 | β |
| Behavioral Treatments for Alcohol Use Disorder and Post-Traumatic Stress Disorder. | Flanagan JC et al. | β | 2018 | β |
| Borderline personality disorder and substance use disorders: an updated review. | Trull TJ et al. | β | 2018 | β |
| Course of remission from and relapse to heavy drinking following outpatient treatment of alcohol use disorder. | Maisto SA et al. | β | 2018 | β |
| Different functional domains measured by cocaine self-administration under the progressive-ratio and punishment schedules in male Wistar rats. | Datta U et al. | β | 2018 | β |
| Event-Related Potentials as Biomarkers of Behavior Change Mechanisms in Substance UseΒ Disorder Treatment. | Houston RJ et al. | β | 2018 | β |
| GABA<sub>A</sub> receptor polymorphisms in alcohol use disorder in the GWAS era. | Koulentaki M et al. | β | 2018 | β |
| Intensity of Daily Drinking and Its Relation to Alcohol Use Disorders. | VergΓ©s A et al. | β | 2018 | β |
| Is shame a proximal trigger for drinking? A daily process study with a community sample. | Luoma JB et al. | β | 2018 | β |
| Mining the nucleus accumbens proteome for novel targets of alcohol self-administration in male C57BL/6J mice. | Faccidomo S et al. | β | 2018 | β |
| Negative Urgency Mediates the Relation between Genetically-Influenced Serotonin Functioning and Alcohol Problems. | Wang FL et al. | β | 2018 | β |
| Overcoming the "Valley of Death" in Medications Development for Alcohol Use Disorder. | Ray LA et al. | β | 2018 | β |
| Patterns of co-occurring addictions, posttraumatic stress disorder, and major depressive disorder in detoxification treatment seekers: Implications for improving detoxification treatment outcomes. | Anderson RE et al. | β | 2018 | β |
| PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age. | Vijay A et al. | β | 2018 | β |
| Post-GWAS in Psychiatric Genetics: A Developmental Perspective on the "Other" Next Steps. | Dick DM et al. | β | 2018 | β |
| Practical outpatient pharmacotherapy for alcohol use disorder. | Kim Y et al. | β | 2018 | β |
| Precision Medicine in Alcohol Dependence: A Controlled Trial Testing Pharmacotherapy Response Among Reward and Relief Drinking Phenotypes. | Mann K et al. | β | 2018 | β |
| Preliminary evaluation of a human laboratory model of impaired control over alcohol using intravenous alcohol self-administration. | Wardell JD et al. | β | 2018 | β |
| Serotonin functioning and adolescents' alcohol use: A genetically informed study examining mechanisms of risk. | Wang FL et al. | β | 2018 | β |
| Testing variability in response to a brief alcohol intervention: The role of self-regulation and the therapeutic relationship. | Lopez-Vergara HI et al. | β | 2018 | β |
| Treatment for Alcohol Use Disorder: Progress in Predicting Treatment Outcome and Validating Nonabstinent End Points. | Creswell KG et al. | β | 2018 | β |
| Typology of Substance Use Disorder Based on Temperament Dimensions, Addiction Severity, and Negative Emotions. | Saberi Zafarghandi MB et al. | β | 2018 | β |
| Addictions Neuroclinical Assessment: A reverse translational approach. | Kwako LE et al. | β | 2017 | β |
| A genetic marker of risk in HIV-infected individuals with a history of hazardous drinking. | Barker DH et al. | β | 2017 | β |
| Analysis of alcohol use disorders from the Nathan Kline Institute-Rockland Sample: Correlation of brain cortical thickness with neuroticism. | Zhao Y et al. | β | 2017 | β |
| A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence. | Ryan ML et al. | β | 2017 | β |
| A preclinical model for identifying rats at risk of alcohol use disorder. | Jadhav KS et al. | β | 2017 | β |
| A prospective study of genetic factors, human laboratory phenotypes, and heavy drinking in late adolescence. | Hendershot CS et al. | β | 2017 | β |
| Differential potassium channel gene regulation in BXD mice reveals novel targets for pharmacogenetic therapies to reduce heavy alcohol drinking. | Rinker JA et al. | β | 2017 | β |
| Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recovery. | Savulich G et al. | β | 2017 | β |
| Effects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies. | Hendershot CS et al. | β | 2017 | β |
| Genetic studies of alcohol dependence in the context of the addiction cycle. | Reilly MT et al. | β | 2017 | β |
| Independent and Interactive Effects of OPRM1 and DAT1 Polymorphisms on Alcohol Consumption and Subjective Responses in Social Drinkers. | Weerts EM et al. | β | 2017 | β |
| Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects. | Hinton DJ et al. | β | 2017 | β |
| Motivation to change and posttreatment temptation to drink: a multicenter study among alcohol-dependent patients. | Fiabane E et al. | β | 2017 | β |
| Neural connectivity in Internet gaming disorder and alcohol use disorder: A resting-state EEG coherence study. | Park SM et al. | β | 2017 | β |
| Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity. | Cservenka A et al. | β | 2017 | β |
| Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders. | Kwako LE et al. | β | 2016 | β |
| An Animal Model of Alcohol Dependence to Screen Medications for Treating Alcoholism. | Becker HC et al. | β | 2016 | β |
| Brain mechanisms of Change in Addictions Treatment: Models, Methods, and Emerging Findings. | Chung T et al. | β | 2016 | β |
| Characterization of comorbid PTSD in treatment-seeking alcohol dependent inpatients: Severity and personality trait differences. | Sells JR et al. | β | 2016 | β |
| Cognitive Control and Negative and Positive Valence Systems in the Development of an NIMH RDoC-Based Model for Alcohol Use Disorder. | SΓ‘nchez E et al. | β | 2016 | β |
| Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse. | Van Skike CE et al. | β | 2016 | β |
| Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokers. | Roche DJ et al. | β | 2016 | β |
| Determining optimal diagnostic criteria through chronicity and comorbidity. | Steinley D et al. | β | 2016 | β |
| Discovery, Development, and Adoption of Medications to Treat Alcohol Use Disorder: Goals for the Phases of Medications Development. | Litten RZ et al. | β | 2016 | β |
| Emerging Pharmacologic Treatments for Adolescent Substance Use: Challenges and New Directions. | Miranda R et al. | β | 2016 | β |
| Habitual Alcohol Seeking: Neural Bases and Possible Relations to Alcohol Use Disorders. | Corbit LH et al. | β | 2016 | β |
| Meta-analysis of DSM alcohol use disorder criteria severities: structural consistency is only 'skin deep'. | Lane SP et al. | β | 2016 | β |
| Motivational Processes Underlying Substance Abuse Disorder. | Meyer PJ et al. | β | 2016 | β |
| Neurobiologic Advances from the Brain Disease Model of Addiction. | Volkow ND et al. | β | 2016 | β |
| Nociceptin Receptor as a Target to Treat Alcohol Use Disorder: Challenges in Advancing Medications Development. | Litten RZ | β | 2016 | β |
| Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety. | Litten RZ et al. | β | 2016 | β |
| Sex Differences in Animal Models: Focus on Addiction. | Becker JB et al. | β | 2016 | β |
| Subjective Response to Alcohol as a Research Domain Criterion. | Ray LA et al. | β | 2016 | β |
| Microstructural analysis of rat ethanol and water drinking patterns using a modified operant self-administration model. | Robinson SL et al. | β | 2015 | β |
| Moving the Alcohol Addiction RDoC forward. | Sher KJ | β | 2015 | β |
| Opportunities for opening the door to transdiagnostic approaches. | Teesson M | β | 2015 | β |
| Recommendations for the Design and Analysis of Treatment Trials for Alcohol Use Disorders. | Witkiewitz K et al. | β | 2015 | β |
| Response to Tucker & Vuchinich (2015): Behavioral economics in the broader context of addiction science. | Amlung M et al. | β | 2015 | β |